<qa>  What is the name of the CYTARABINE that is a CYTARABDECITABINE FOLLOWED BY MITOXANTRONE HYDROCHLORIDE, ETOPOSIDE, AND CYTARABINE IN TREATING PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA OR HIGH-RISK MYELODYSPLASTIC SYNDROMES: 